Some generics can cost Medicare recipients more than brand-name drugs

According to new research by health policy experts at Vanderbilt University Medical Center and the University of North Carolina at Chapel Hill, they found Medicare Part D enrollees may pay more out of pocket for high-priced specialty generic drugs than their brand-name counterparts. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.